European Medicines Agency recommends approval of a new medicine for multidrug-resistant tuberculosis

View source ↗

Summary

EMA recommends approval of a new medicine for multidrug-resistant tuberculosis, marking a potential new treatment option for this challenging infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis